Fulgent Genetics Receivables 2015-2024 | FLGT

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Fulgent Genetics receivables from 2015 to 2024. Receivables can be defined as the total amount of collectibles for a company

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Fulgent Genetics receivables from 2015 to 2024. Receivables can be defined as the total amount of collectibles for a company

Related Stocks
Company Name	Market Cap
GE HealthCare Technologies (GEHC)	$40.4B
Tempus AI (TEM)	$7.9B
Inspire Medical Systems (INSP)	$6.2B
Axonics (AXNX)	$3.5B
Hims & Hers Health (HIMS)	$3.5B
10x Genomics (TXG)	$2.7B
Enovis (ENOV)	$2.4B
Azenta (AZTA)	$2.4B
Privia Health (PRVA)	$2.3B
IRhythm Technologies (IRTC)	$2.2B
Omnicell (OMCL)	$2B
Clover Health Investments (CLOV)	$1.5B
Schrodinger (SDGR)	$1.4B
Phreesia (PHR)	$1.4B
Standard BioTools (LAB)	$753M
Definitive Healthcare (DH)	$538M
Health Catalyst (HCAT)	$529M
Butterfly Network (BFLY)	$406M
Talkspace (TALK)	$343M
Pulmonx (LUNG)	$329M
SOPHiA GENETICS SA (SOPH)	$286M
TruBridge (TBRG)	$183M
P3 Health Partners (PIII)	$165M
American Well (AMWL)	$147M
Augmedix (AUGX)	$115M
EUDA Health Holdings (EUDA)	$90M
Future Health ESG (FHLT)	$65M
SHL Telemedicine (SHLT)	$55M
HeartBeam (BEAT)	$53M
111 (YI)	$51M